Category

AUTOINMMUNE DISEASES

Home > Therapeutic Areas > AUTOINMMUNE DISEASES (Page 3)

Martínez N, Villar O, Armijo O, Castellanos M, Marin-Huarte N, Mareque M, Casado MA, Martínez-Barrio J

 

 

Impacto económico asociado a eventos obstétricos en mujeres en edad fértil con artritis psoriásica, artritis reumatoide, espondiloartritis axial y psoriasis en España
Reumatología Clínica:10.1016/j.reuma.2020.09.006

Navarro F, Martinez-Sesmero JM, Balsa A, Peral C, Montoro M, Valderrama M, Gómez S, de Andrés-Nogales F, Casado MA, Oyagüez I

 

 

Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
Clin Reumatol 2020;39:2919-30

Gónzalez-Lama Y, García -Vivar ML, Muñoz C, Trujillo E, Carrillo M, Juanola X, Guardiola J, Pérez-Pampín E, Barreiro-de Acosta M, Gonzalez CM, Marin I, Queiro R, Riestra S, Burgos-Pol R, Oyagüez I, Oliva M, Benyaich GK, Sanz J

 

Situación actual del abordaje multidisciplinar entre reumatología y gastroenterología en España
Congreso Sociedad Española de Patología Digestiva (SEPD). Virtual-II parte 18-20 jun 2020

Castañeda S, Vicente E, Llamas-Velasco M, Sanchez-Perez J, Pardo J, Cabeza-Martínez R, Miranda-Fontes M, Márquez J, Calvo J, Armesto S, Belinchón I, Gómez A, Miranda MD, Martinez-Pardo S, Merino-Meléndez L, Casado MA, Yébenes M, Casado A

Cost of illness in patients with psoriasis and psoriatic arthritis. COEPSO Study
European Congress of Rheumatology 2020 (EULAR). Virtual- Frankfurt (Alemania). 3-6 jun 2020

Llamas-Velasco M, Castañeda S, Sánchez-Pérez J, Vicente-Rabaneda EF, Pardo J, Cabeza-Martínez R, Miranda Fontes M, Márquez J, Calvo-Alén J, Armesto S, Belinchón I, Gómez A, Miranda MD, Martínez Pardo S, Merino L, Casado MA, Amaro A, Ordovás M, Yébenes M, Casado A

Cost of illness in patients with psoriasis and psoriatic arthritis disease. COEPSO Study
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019

POSTER

Taxonera C, de Andrés-Nogales F, García S, Sánchez-Guerrero A, Menchen B, Peral C, Cábez A, Gómez S, López A, Casado MÁ, Menchén L

 

 

Cost-effectiveness of Tofacitinib for the Treatment of Moderate-to-severe Ulcerative Colitis After Conventional Therapy in Spain
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019

POSTER

Menchén L, de Andrés-Nogales F, García S, Sánchez-Guerrero A, Menchen B, Cábez A, Gómez S, López A, Casado MÁ, Peral C, Taxonera C

 

Cost-effectivenes of Tofacitinib for the Treatment of Moderate-to-severe Ulcerative Colitis After Biologic Failure or Intolerance in Spain
22nd Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019

POSTER

Puig L, Fernández-Freire LR, Burgos-Pol R, Gomez I, Peral C, Gomez S, Rebollo Laserna FJ

 

 

Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
Dermatol Ther (Heidelb). doi: 10.1007/s13555-019-0301-6

Peral C, Balsa A, Pablos JL, Navarro F, Martínez-Sesmero JM, Montoro M, Gómez S, Valderrama M, de Andrés-Nogales F, Casado MA, Oyagüez I

 

 

Efficiency of treatment sequences containing tofacitinib for rheumatoid arthritis in Spain
European Congress of Rheumatology 2019 (EULAR). Madrid. 12-15 jun 2019